Vertex Pharmaceuticals
Venture capital · Boston, Massachusetts, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
4Deep-tech portfolio2 active
2Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Orna Therapeutics
15Co-investorsShare a portfolio company
Portfolio · 4 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Kymera Therapeutics | Biotech | Active | — | — |
| Skyhawk Therapeutics | Biotech | Active | — | — |
| Orna Therapeutics | Biotech | Acquired | — | — |
| Sionna Therapeutics | Biotech | Public | — | — |
Peer ranks
Portfolio size#108
Portfolio exits#103
Raises, 12 months#88
Co-investors#133
Co-investors
- Atlas VentureVenture capital2 shared
- Alexandria Venture InvestmentsVenture capital1 shared
- Apple Tree PartnersVenture capital1 shared
- Bay City CapitalVenture capital1 shared
- Biotechnology Value FundVenture capital1 shared
- EcoR1 CapitalVenture capital1 shared
- Eli LillyVenture capital1 shared
- Logos CapitalVenture capital1 shared
- MPM CapitalVenture capital1 shared
- MRL Ventures FundVenture capital1 shared
Sectors
- Biotech4
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.